Werner Müller Selected Research

Werner Müller Research Topics

Disease

25	Inflammation (Inflammations) 01/2020 - 09/2004
14	Infections 01/2019 - 03/2003
8	Neoplasms (Cancer) 01/2022 - 08/2007
8	Colitis 05/2014 - 09/2008
6	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019 - 06/2008
4	Contact Dermatitis (Eczema, Contact) 06/2011 - 11/2004
4	Acute-Phase Reaction 11/2009 - 08/2003
3	Atherosclerosis 01/2018 - 08/2007
3	Hypersensitivity (Allergy) 08/2012 - 10/2009
2	Polyps 11/2021 - 01/2007
2	Necrosis 01/2021 - 12/2006
2	Infarction (Infarctions) 01/2019 - 07/2010
2	Crohn Disease (Crohn's Disease) 01/2019 - 06/2008
2	Obesity 01/2018 - 01/2016
2	Myocardial Infarction 01/2018 - 07/2010
2	Insulin Resistance 01/2018 - 01/2016
2	Anorexia 11/2017 - 07/2006
2	Bacterial Infections (Bacterial Infection) 05/2014 - 01/2012
2	Anemia 05/2014 - 09/2006
2	Encephalitis (Encephalitis, Rasmussen) 07/2012 - 05/2003
2	Cardiovascular Diseases (Cardiovascular Disease) 05/2011 - 08/2007
2	Endotoxemia 02/2010 - 08/2009
1	Hyperparathyroidism 02/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Cleft Lip (Harelip) 11/2021
1	Leg Ulcer 09/2021
1	Hemolysis 09/2019
1	Neuroinflammatory Diseases 01/2019
1	Buruli Ulcer 01/2019
1	Ulcerative Colitis 01/2019
1	Hyperthermia 01/2019
1	Ischemic Stroke 01/2019
1	Brain Injuries (Brain Injury) 01/2019
1	Trichuriasis 01/2019
1	Dysbiosis 01/2019
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2018
1	Glucose Intolerance 01/2018
1	Thrombosis (Thrombus) 01/2018
1	Fever (Fevers) 11/2017

Drug/Important Bio-Agent (IBA)

25	CytokinesIBA 01/2019 - 11/2004
24	Interleukin-10 (Interleukin 10)IBA 01/2019 - 11/2004
12	Interleukin-6 (Interleukin 6)IBA 01/2018 - 07/2003
7	Interleukin-10 ReceptorsIBA 01/2019 - 02/2010
5	Interleukin-1 (Interleukin 1)IBA 01/2020 - 04/2016
4	InterleukinsIBA 01/2018 - 11/2009
4	ChemokinesIBA 01/2016 - 06/2008
4	AntigensIBA 05/2014 - 09/2010
3	Proteins (Proteins, Gene)FDA Link 01/2017 - 05/2008
3	Dextran SulfateIBA 01/2016 - 09/2008
3	InterferonsIBA 01/2016 - 09/2013
3	IntegrinsIBA 01/2012 - 12/2003
2	fluorocholineIBA 02/2022 - 01/2017
2	CalciumIBA 11/2021 - 01/2017
2	calcium phosphateIBA 11/2021 - 01/2016
2	RNA (Ribonucleic Acid)IBA 01/2021 - 11/2008
2	Immunoglobulin G (IgG)IBA 01/2018 - 04/2008
2	Insulin (Novolin)FDA Link 01/2018 - 09/2014
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2017 - 06/2008
2	Hormones (Hormone)IBA 11/2017 - 01/2016
2	LipidsIBA 01/2016 - 05/2014
2	Granzymes (Granzyme)IBA 08/2014 - 06/2012
2	Interleukin-12 (IL 12)IBA 11/2013 - 10/2011
2	Acute-Phase Proteins (Acute-Phase Protein)IBA 05/2011 - 08/2007
2	LigandsIBA 10/2009 - 08/2007
2	Cytokine Receptor gp130IBA 10/2009 - 08/2003
2	DNA (Deoxyribonucleic Acid)IBA 11/2008 - 03/2003
1	Chimeric Antigen ReceptorsIBA 01/2022
1	Epithelial Cell Adhesion MoleculeIBA 01/2022
1	PolyphosphatesIBA 11/2021
1	Phosphates (Orthophosphate)IBA 11/2021
1	hydroxyapatite-beta tricalcium phosphateIBA 11/2021
1	PolymersIBA 11/2021
1	SolutionsIBA 09/2021
1	AcidsIBA 09/2021
1	AnticoagulantsIBA 09/2019
1	Tamoxifen FDA LinkGeneric 01/2019
1	Cre recombinaseIBA 01/2019
1	LuciferasesIBA 01/2019
1	Cholinergic Agents (Cholinergics)IBA 01/2019
1	Interferon Type IIBA 10/2018
1	Ribonucleases (Ribonuclease)IBA 10/2018
1	RibonucleotidesIBA 10/2018
1	CollagenIBA 01/2018
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2018
1	Apolipoproteins E (ApoE)IBA 01/2018
1	LeptinIBA 01/2018
1	AntibodiesIBA 01/2018
1	Nonesterified Fatty Acids (NEFA)IBA 01/2018
1	Pattern Recognition ReceptorsIBA 01/2018
1	canakinumab FDA Link 01/2018
1	Messenger RNA (mRNA)IBA 12/2017
1	tocilizumab (atlizumab)FDA Link 11/2017
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 11/2017
1	Etanercept (Enbrel)FDA Link 11/2017

Therapy/Procedure

4	Therapeutics 01/2022 - 01/2014
1	Operative Surgical Procedures 11/2021
1	Bone Transplantation (Bone Grafting) 11/2021
1	Induced Hyperthermia (Thermotherapy) 01/2019